ライフサイエンスコーパス: echocardiographic finding

1 ts with LQTS, making it a routinely reported echocardiographic finding.

2 ce of clinical symptoms of heart failure and echocardiographic findings.

3 r adjusting for donor clinical variables and echocardiographic findings.

4 ave been modified based on three-dimensional echocardiographic findings.

5 atheterization measurements and diagnosed by echocardiographic findings.

6 tral venous pressure >15 mmHg and consistent echocardiographic findings.

7 ar imaging for preliminary interpretation of echocardiographic findings.

8 nd aortic insufficiency were the predominant echocardiographic findings.

9 a cardiac assist device and is compared with echocardiographic findings.

10 based on the yielding of blood cultures and echocardiographic findings.

11 Based on echocardiographic findings, a diagnosis of infective veg

12 dy was to evaluate the relationships between echocardiographic findings and clinical outcomes in pati

13 eight, congestive heart failure, or abnormal echocardiographic findings, and by the presence of multi

14 rding MR development, clinical presentation, echocardiographic findings, and management strategies we

15 as undertaken that used the medical history, echocardiographic findings, and surgical data of patient

16 Outcome was related to the exercise and echocardiographic findings, and the incremental prognost

17 uations: when clinical suspicion is high but echocardiographic findings are inconclusive; when there

18 Echocardiographic findings, as well as the clinical cour

19 ght to identify shunt-related differences in echocardiographic findings at 14 months and </=6 months

20 chronic lung disease, previous acute HF) and echocardiographic findings at discharge (grade III or IV

21 to determine the influence of dexrazoxane on echocardiographic findings at four years and on event-fr

22 Demographic and clinical characteristics and echocardiographic findings at presentation, as well as c

23 ents with negative or difficult-to-interpret echocardiographic findings because it correctly classifi

24 Clinical and echocardiographic findings but not invasive hemodynamics

25 anda National RHD Registry, we described the echocardiographic findings, clinical characteristics, me

26 ndred eight patients (49.5%) had clinical or echocardiographic findings for which prophylaxis was ind

27 nt and those who did not had similar overall echocardiographic findings, hemodynamics, 6MWD and NT-pr

28 Tricuspid regurgitation is a frequent echocardiographic finding; however, the association with

29 Mitral regurgitation (MR) is a common echocardiographic finding; however, there is no simple a

30 This study aimed to compare echocardiographic findings in low-risk patients with sev

31 heart and vascular bed, and descriptions of echocardiographic findings in obese children, children e

32 -center study that evaluated transesophageal echocardiographic findings in patients randomly assigned

33 This study sought to compare echocardiographic findings in patients with critical aor

34 rapy on vascular markers of inflammation and echocardiographic findings in patients with nonischemic

35 Study compared clinical outcomes and serial echocardiographic findings in patients with severe aorti

36 he utility of electrocardiographic (ECG) and echocardiographic findings in the diagnosis of amyloidos

37 Echocardiographic findings included a markedly elevated

38 Echocardiographic findings, including hemodynamic valve

39 Consistent with its clinical benefits, these echocardiographic findings indicate favorable effects of

40 pment of atrial fibrillation, fluid balance, echocardiographic findings, medication administration, a

41 Neither echocardiographic findings nor vascular calcification sc

42 ody weight ratio, which was confirmed by the echocardiographic finding of an increased thickness of t

43 ram database identified 212 patients who had echocardiographic findings of CP from 1988 through 1999.

44 ermore, cMyBP-C(t3SA) hearts exhibited basal echocardiographic findings of systolic dysfunction, dias

45 Early echocardiographic findings of the Duke criteria were not

46 t interventions, comorbidities, medications, echocardiographic findings, presenting symptoms, course

47 Prevalence of other comorbidities, echocardiographic findings, prophylactic penicillin pres

48 ed manner for serious disorders with classic echocardiographic findings (pulmonary hypertension, left

49 anced heart failure, immediate postoperative echocardiographic findings remain abnormal.

50 Echocardiographic findings suggestive of subclinical con

51 By matching echocardiographic findings to the appropriate surgical s

52 Dobutamine-atropine stress echocardiographic findings were classified according to

53 The clinical and echocardiographic findings were compared between the rec

54 The echocardiographic findings were compared with those in 5

55 Demographic, clinical, and echocardiographic findings were identified in all patien

56 gathered prospectively, and hemodynamic and echocardiographic findings were recorded at each stage,

57 inclusion and after 12 mo, clinical data and echocardiographic findings were recorded, and laboratory

58 sence of valvular disease nor changes in the echocardiographic findings were temporally related to th

59 lcification of mitral annulus is rather rare echocardiographic finding with prevalence of 0.6% in pts

60 arditis and correlated postoperative Doppler echocardiographic findings with clinical status.